Ibuprofen is a common over-the-counter (OTC) pain relieving pill, which comes in category of non-steroidal anti-inflammatory drugs, or NSAID. NSAIDs are usually indicated for the treatment of acute or chronic conditions, where pain and inflammation are present. A study suggests that regular use of ibuprofen can reduce the risk of Parkinson’s disease. Parkinson’s disease is mental disorder that is characterized by body tremors and movement problems, which is mostly found in elderly people.
What does ibuprofen study involve?
A study was lead by Xiang Gao, research scientist at Harvard School of Public Health and instructor of medicine at Harvard Medical School. Data regarding use of ibuprofen and other NSAIDs pain relievers such as Advil or Mortin from 136,197 nurses and other health professionals was collected and analyzed. The study is said to be one of the largest to investigate the possible benefits of ibuprofen on Parkinson’s and was published in the online edition of the journal Neurology.
What were results of ibuprofen Parkinson’s disease study?
The Harvard study revealed that after six years:
- 291 participants were diagnosed with Parkinson’s
- people who took ibuprofen regularly had a 38% lower risk of developing the disorder compared with those who didn’t use it.
- Meta analysis of several studies on ibuprofen and other NSAIDs showed ibuprofen users had a 27% lower risk of developing the disease.
Why would ibuprofen be effective in reducing risk of Parkinson’s disease?
This is a new development in...
medical science and exact cause of effectiveness of ibuprofen is not known yet. But, Alessandro Di Rocco, director of the Parkinson’s and Movement Disorders Division at NYU’s Langone Medical Center revealed that “The idea that there is inflammation involved in the process of Parkinson’s is not new.” NSAIDs are effective against inflammation, and hence may help Parkinson’s patients.
Should I start taking ibuprofen to avert Parkinson’s disease?
James Bower, an associate professor of neurology at the Mayo Clinic in Rochester, Minn stated that “It’s too early for doctors to prescribe ibuprofen to prevent Parkinson’s, which affects about 1 million Americans, says the author of an accompanying editorial.” Although the study is said to be sound by Bower, but this is still early development and ibuprofen should not be taken regularly for Parkinson’s disease, without further evidence or direction from regulatory bodies. Ibuprofen can have serious side effects to kidney, liver, stomach and urological complications.
The study is promising and a step towards helping Parkinson’s disease patients. If you are suffering from Parkinson’s or have a family history of risk towards Parkinson’s disease, consult your doctor about using ibuprofen being aware of the known side effects.